SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements.Clinical.Corporate.Regulatory 24.03.2021
Investor Presentation – Daiwa Investment Conference Tokyo 2021 2021 Announcements . Presentation 10.03.2021
Financial Results Half Year Ended 31 December 2020 2021 Announcements . Financial . Newsletter 19.02.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021